Sales and Marketing

Following on from our focus on biosimilars in our feature last week, you can read Nikhil Patel’s interview with Sang-Jin …

The Louisiana Department of Public Safety and Corrections (LDPSC) and BioCorRx Inc are alleged to have collaborated in testing an …

NICE has given its recommendation for the routine use on the NHS in England and Wales of AstraZeneca and MSD’s …

The Labour Party and the Liberal Democrats have both pledged to roll out access to pre-exposure prophylaxis (PrEP) therapy for …

A former Labour Party health minister has said that the British pharmaceutical industry is “under threat” from a Jeremy Corbyn …

Roche has presented new data on its interleukin-6 (IL-6) inhibitor satralizumab in the treatment of neuromyelitis optica spectrum disorder (NMOSD), …

The NHS was featured heavily in the news this week. Jeremy Corbyn revealed documents detailing previous UK-US discussions in which …

Labour Leader Jeremy Corbyn has showed off documents that detail secret trade meetings between the US and UK Governments, where …

The Institute for Clinical and Economic Review (ICER) has unveiled a new report comparing the clinical efficacy and cost-effectiveness of …

The European Commission has chosen to authorise Celltrion Healthcare’s Remsima SC, a biosimilar of infliximab and the first subcutaneous formulation …

With more and more biosimilars securing approval and the sheer potential value they have to offer for healthcare systems around …

One of Sanofi’s most senior strategy bosses is set to retire at the end of the month. Muzammil Mansuri, Executive …

The FDA has approved AstraZeneca’s BTK inhibitor Calquence (acalabrutinib) in the treatment of chronic lymphocytic leukaemia (CLL) and small lymphocytic …

The FDA has granted a Breakthrough Therapy designation to the Usona Institute for its trial use of psilocybin in the …

Novartis agreed a $9.7 billion deal to acquire the US-based The Medicines Company, it announced Sunday. The transaction was unanimously …